FDA Inspection
Quagen Pharma, LLCQuagen Pharma, LLC – FDA Inspection, May 9, 2023
Record Details
This FDA Inspection record concerns Quagen Pharma, LLC, with an inspection on May 9, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 666fc434-9541-4099-b5b5-1371247a8209
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1207909
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Quagen Pharma, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2026 | Not classified | New Jersey District Office | |
| October 26, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2019 | Not classified | New Jersey District Office |
Other documents for Quagen Pharma, LLC
- FDA Inspection 1306964 - 2026-04-17
- FDA Inspection 1131910 - 2020-10-26
- FDA Inspection 1082687 - 2019-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.